| Outcome Measures: |
Primary: AUCGIR.0-12h, Area under the glucose infusion rate-time curve from time 0 until end of clamp, From t=0 to t=12 hours after IMP administration|AUCGIR.0-1h, Area under the glucose infusion rate-time curve from time 0 to 1 hour after IMP administration, From t=0 to t=1 hour after IMP administration|AUCLIS.0-12h, Area under the insulin lispro concentration-time curve from 0 hours to 12 hours after dose administration, From t=0 to t=12 hours after IMP administration|AUCLIS.0-1h, Area under the insulin lispro concentration-time curve from 0 hours to 1 hour after dose administration, From t=0 to t=1 hour after IMP administration | Secondary: tmax.LIS, Time to maximum observed insulin lispro concentration, From t=0 to t=12 hours after IMP administration|Cmax.LIS, Maximum observed insulin lispro concentration, From t=0 to t=12 hours after IMP administration|AUCLIS.2-6h, Area under the insulin lispro concentration-time curve from 2 hour to 6 hour after dose administration, From t=2 to t=6hours after IMP administration|t50%-LIS (early), Time to half-maximum before Cmax.LIS, From t=0 to t=12 hours after IMP administration|tmax.GIR, Time to maximum glucose infusion rate, From t=0 to t=12 hours after IMP administration|GIRmax, Maximum glucose infusion rate, From t=0 to t=12 hours after IMP administration|AUCGIR.4-8h, Area under the glucose infusion rate-time curve from 4 to 8 hours after dose administration, From t=4 to t=8 hours after IMP administration
|
